Abdomen 2 Final Exam Flashcards
Contrast enhancement lasts longest when administering the ultrasound contrast agent by:
Slow infusion
Currently in the United States, which of the following contrast agents are available and approved by the U.S. Food and Drug Administration (FDA) for use in echocardiography?
Definity, Optison, Imagent
Depending on the clinical application, vascular UCAs may be administered via:
Intravenous infusion
Evaluation of a patient with known cirrhosis often demonstrates a(n):
Reduced portal venous flow with an increase in hepatic artery flow.
For a vascular ultrasound contrast agent to be clinically useful, it should:
Have all of the above
Hepatic cavernous hemangioma demonstrate peripheral enhancement only during the:
Arterial phase
In harmonic-imaging mode, the echoes from the oscillating microbubbles have a:
High signal-to-noise ratio
In the early arterial phase, using tissue-specific contrast agents, focal nodular hyperplasia can have a similar appearance to a:
Hepatocellular carcinoma (HCC)
Induced acoustic-emission effects are independent of:
Contrast motion
Most of the research and development of ultrasound contrast agents (UCAs) has centered on creating agents that can:
Be administered intravenously
Several reports have described the contrast-enhanced sonographic appearance of hepatocellular carcinoma as having intense enhancement in the _____________ phase.
Early arterial
The detection of flow in the hepatic capillaries is identified in the ___________ phase.
Late vascular
The first ultrasound contrast agent to receive FDA approval was used in:
Echocardiography
The mechanical index (MI) uses:
Low acoustic output power
The microbubble of a first-generation UCA contains which one of the following types of substance?
Room air
The microbubbles of tissue-specific UCAs are:
Taken up by or have an affinity for specific tissues
The rupture of microbubbles results in random:
Doppler shifts
Tissue-specific ultrasound contrast agents can be considered to be:
Molecular-imaging agents
To aid in contrast-enhanced imaging equipment, manufacturers have begun to incorporate into their systems:
Intermittent imaging capabilities
Ultrasound contrast agents have shown the potential to improve the accuracy of hepatic sonography including:
All of the above
Vascular ultrasound agents enhance Doppler flow signals by:
Adding more and better acoustic scatterers to the bloodstream
When insonating microbubble-based UCAs, the energy present within the acoustic field:
Can have a detrimental effect on the contrast microbubbles
When the microbubble is destroyed:
Contrast enhancement is no longer provided.
When using ultrasound contrast agents, a lesion that gets progressively echogenic over time is most likely:
Hemangioma